The Influence of Alpha Kinase 2 Expression on Prognosis in Serous Ovarian Cancer Liver Metastasis

Table 1

Clinical characteristics of OCLM patients.

Variables	Cases	ALPK2 expression level		value
	(n = 49)	Low (n = 24)	High (n = 25)
Age (years)				1.000
≤60 yrs	21	10	11
>60 yrs	28	14	14
Laterality				0.520
Unilateral	13	5	8
Bilateral	36	19	17
Lymph node status				0.244
Negative	19	7	12
Positive	30	17	13
Chemotherapy				0.725
Yes	40	19	21
No	9	5	4

OCLM, ovarian cancer liver metastases; ALPK2, alpha kinase 2. Note. Data were tested by the two-sided Fisher exact test.